chr1-151760903-C-CAA
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_031420.4(MRPL9):c.589-5_589-4insTT variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.19 ( 1889 hom., cov: 0)
Exomes 𝑓: 0.099 ( 482 hom. )
Consequence
MRPL9
NM_031420.4 splice_region, splice_polypyrimidine_tract, intron
NM_031420.4 splice_region, splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.153
Genes affected
MRPL9 (HGNC:14277): (mitochondrial ribosomal protein L9) This is a nuclear gene encoding a protein component of the 39S subunit of the mitochondrial ribosome. Alternative splicing results in multiple transcript variants. A pseudogene of this gene is found on chromosome 8. [provided by RefSeq, Jul 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 1-151760903-C-CAA is Benign according to our data. Variant chr1-151760903-C-CAA is described in ClinVar as [Benign]. Clinvar id is 403108.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.262 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MRPL9 | NM_031420.4 | c.589-5_589-4insTT | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000368830.8 | |||
MRPL9 | NM_001300733.2 | c.487-5_487-4insTT | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ||||
MRPL9 | NR_125331.2 | n.646-5_646-4insTT | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MRPL9 | ENST00000368830.8 | c.589-5_589-4insTT | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_031420.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.189 AC: 14017AN: 74010Hom.: 1891 Cov.: 0
GnomAD3 genomes
AF:
AC:
14017
AN:
74010
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0994 AC: 83209AN: 836750Hom.: 482 Cov.: 0 AF XY: 0.0987 AC XY: 41054AN XY: 415996
GnomAD4 exome
AF:
AC:
83209
AN:
836750
Hom.:
Cov.:
0
AF XY:
AC XY:
41054
AN XY:
415996
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.189 AC: 14013AN: 74002Hom.: 1889 Cov.: 0 AF XY: 0.187 AC XY: 6324AN XY: 33870
GnomAD4 genome
AF:
AC:
14013
AN:
74002
Hom.:
Cov.:
0
AF XY:
AC XY:
6324
AN XY:
33870
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at